What is Dyne Therapeutics, Inc.'s operating lease liabilities?

Dyne Therapeutics, Inc. (DYN) reported operating lease liabilities of $14.27M in Q1 2026.

How has Dyne Therapeutics, Inc.'s operating lease liabilities changed year-over-year?

Dyne Therapeutics, Inc.'s operating lease liabilities decreased by 21.7% year-over-year, from $18.22M to $14.27M.

What does operating lease liabilities mean?

Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.

Dyne Therapeutics, Inc. DYN Operating Lease Liabilities

Operating Lease Liabilities at other companies

Ionis PharmaceuticalsIONS

$259.22M+62.6%

Arrowhead ResearchARWR

$100.11M-6.9%

Edgewise Therapeutics, Inc.EWTX

$2.78M-22.0%

PTC TherapeuticsPTCT

$90.07M+22.4%

Scholar RockSRRK

$2.98M-62.3%

Catalyst PharmaceuticalCPRX

$2.24M-16.6%

Other financials

Income statement

See full

Operating income-$125.3M-2.4%

Net income-$120.9M-4.8%

EPS (diluted)-$0.73+30.5%

Balance sheet

See full

Cash & equivalents$753.1M+59.5%

Total debt$168.7M+623%

Total equity$865.1M+29.3%

Total assets$1.1B+49.8%

Cash flow

See full

Operating cash flow-$144.9M-36.9%

CapEx$221.0K-77.5%

Free cash flow-$145.1M-35.8%

Valuation

See full

Market cap$3.35B+153%

Returns & leverage

See full

Return on equity-58.9%-4.4pp

Debt / equity0.2×+0.2×

Current ratio19.9×-0.4×

Where this comes from

Reported directly by Dyne Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dyne Therapeutics, Inc.'s operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dyne Therapeutics, Inc.'s operating lease liabilities?: Dyne Therapeutics, Inc. (DYN) reported operating lease liabilities of $14.27M in Q1 2026.
How has Dyne Therapeutics, Inc.'s operating lease liabilities changed year-over-year?: Dyne Therapeutics, Inc.'s operating lease liabilities decreased by 21.7% year-over-year, from $18.22M to $14.27M.
What does operating lease liabilities mean?: Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.